Convery Erin, Shin Euy Kyun, Ding Qi, Wang Wei, Douglas Pauline, Davis Laurie S, Nickoloff Jac A, Lees-Miller Susan P, Meek Katheryn
Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI 48824, USA.
Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1345-50. doi: 10.1073/pnas.0406466102. Epub 2005 Jan 24.
Two major DNA double-strand break repair pathways exist in all eukaryotes, nonhomologous DNA end joining (NHEJ) and homologous recombination (HR). Although both pathways can function throughout the cell cycle, NHEJ predominates in G0/G1) (when a replicated sister chromatid is unavailable), whereas HR makes a more substantial contribution in S and G2. How a cell chooses between these two important DNA repair pathways is largely unknown. DNA-dependent protein kinase (DNA-PK) is critical for NHEJ. Here, we describe two conserved splice variants of a catalytic subunit of DNA-PK (DNA-PKcs) that are expressed predominately in nondividing cells. Although both encode stable products, neither reverses the NHEJ defects in DNA-PKcs-deficient cells. In fact, cells expressing one of the DNA-PKcs variants are slightly more radiosensitive than cells completely deficient in DNA-PKcs. We investigated whether cells expressing the DNA-PKcs variants had any other DNA repair deficits and found that these cells are considerably more sensitive to both etoposide and mitomycin C than cells that express no DNA-PKcs at all. Because repair of DNA damage induced by these two agents requires intact HR, we tested whether the NHEJ-defective variants of DNA-PKcs inhibit double-strand break-induced HR in an integrated substrate. In cells expressing the NHEJ-defective variants, HR was markedly reduced. Because the splice variants are expressed highly only in nondividing cells, quiescent cells would be afforded a mechanism to inhibit repair by means of HR when sister chromatids are not available as templates for accurate repair with low risk of genome rearrangement, thereby enhancing genome stability.
所有真核生物中存在两种主要的DNA双链断裂修复途径,即非同源DNA末端连接(NHEJ)和同源重组(HR)。尽管这两种途径在整个细胞周期中都能发挥作用,但NHEJ在G0/G1期占主导地位(此时复制的姐妹染色单体不可用),而HR在S期和G2期发挥更重要的作用。细胞如何在这两种重要的DNA修复途径之间做出选择在很大程度上尚不清楚。DNA依赖蛋白激酶(DNA-PK)对NHEJ至关重要。在此,我们描述了DNA-PK催化亚基(DNA-PKcs)的两种保守剪接变体,它们主要在非分裂细胞中表达。尽管两者都编码稳定的产物,但它们都不能逆转DNA-PKcs缺陷细胞中的NHEJ缺陷。事实上,表达其中一种DNA-PKcs变体的细胞比完全缺乏DNA-PKcs的细胞对辐射更敏感。我们研究了表达DNA-PKcs变体的细胞是否存在其他DNA修复缺陷,发现这些细胞比完全不表达DNA-PKcs的细胞对依托泊苷和丝裂霉素C都敏感得多。由于这两种药物诱导的DNA损伤修复需要完整的HR,我们测试了DNA-PKcs的NHEJ缺陷变体是否会在整合底物中抑制双链断裂诱导的HR。在表达NHEJ缺陷变体的细胞中,HR明显减少。由于剪接变体仅在非分裂细胞中高度表达,当姐妹染色单体不可用作准确修复的模板且基因组重排风险较低时,静止细胞将有一个机制通过HR抑制修复,从而增强基因组稳定性。